ARWR
NASDAQ · Biotechnology
Arrowhead Pharmaceuticals In
$60.77
+4.50 (+8.00%)
Performance
1D
—
1W
—
1M
—
3M
-13.38%
6M
+79.90%
1Y
+336.25%
YTD
-10.36%
Open$57.29
Previous Close$56.27
Day High$62.81
Day Low$57.29
52W High$76.76
52W Low$9.57
Volume—
Avg Volume4.93M
Market Cap8.94B
P/E Ratio44.21
EPS$1.54
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$66.84
Below
SMA 200
$36.65
Above
RSI (14)
36.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+14.4% upside
Current
$60.77
$60.77
Target
$69.50
$69.50
$62.98
$69.50 avg
$88.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 884.70M | 587.76M | 3.64B |
| Net Income | -1,740,554 | -1,040,724 | -138,687,526 |
| Profit Margin | -0.2% | -0.2% | -3.8% |
| EBITDA | 136.03M | 85.86M | -183,881,108 |
| Free Cash Flow | — | — | -98,110,953 |
| Rev Growth | +50.5% | +50.5% | +9.5% |
| Debt/Equity | 1.34 | 1.34 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |